294 results on '"Locati, Laura D."'
Search Results
2. The SINTART 2 Study. A phase II non-randomised controlled trial of induction chemotherapy, photon-, proton- and carbon-ion-based radiotherapy integration in patients with locally advanced unresectable sinonasal tumours
3. Current picture of anaplastic thyroid cancer patients' care and meetable needs: A survey of 94 Institutions from the EORTC Endocrine and Head and Neck Cancer Groups
4. Position paper from the Endocrine Task Force of the European Organisation for Research and Treatment of Cancer (EORTC) on the management and shared decision making in patients with low-risk micro papillary thyroid carcinoma
5. Systemic Therapy in Salivary Gland Carcinoma
6. Prognostic nomogram in patients with metastatic adenoid cystic carcinoma of the salivary glands
7. Major and minor salivary gland tumours
8. The curious phenomenon of dual-positive circulating cells: Longtime overlooked tumor cells
9. Immuno-oncology in head and neck squamous cell cancers: News from clinical trials, emerging predictive factors and unmet needs
10. Improved guidance is needed to optimise diagnostics and treatment of patients with thyroid cancer in Europe
11. Clinical Validity of a Prognostic Gene Expression Cluster-Based Model in Human Papillomavirus–Positive Oropharyngeal Carcinoma
12. Systemic therapy in metastatic salivary gland carcinomas: A pathology-driven paradigm?
13. Management of Salivary Gland Cancer
14. Current management and future challenges in salivary glands cancer
15. Genetic profiling of advanced radioactive iodine-resistant differentiated thyroid cancer and correlation with axitinib efficacy
16. Thyroid Cancer
17. Terapia medica integrata nei carcinomi squamocellulari
18. Management of Salivary Gland Cancer
19. Supplementary Table 2 from Functional Genomics Uncover the Biology behind the Responsiveness of Head and Neck Squamous Cell Cancer Patients to Cetuximab
20. Supplementary Figure 1 from Functional Genomics Uncover the Biology behind the Responsiveness of Head and Neck Squamous Cell Cancer Patients to Cetuximab
21. Supplementary Figure 3 from Functional Genomics Uncover the Biology behind the Responsiveness of Head and Neck Squamous Cell Cancer Patients to Cetuximab
22. Supplementary Figure 4 from Functional Genomics Uncover the Biology behind the Responsiveness of Head and Neck Squamous Cell Cancer Patients to Cetuximab
23. Supplementary Figure 2 from Functional Genomics Uncover the Biology behind the Responsiveness of Head and Neck Squamous Cell Cancer Patients to Cetuximab
24. Implementing a virtual multidisciplinary clinical case discussion to manage rare and complex head and neck cancers: an expert-defined protocol proposal from the Italian Association of Head and Neck Oncology (AIOCC)
25. Immunohistochemical and molecular profile of salivary gland cancer in children
26. Salivary gland cancers in elderly patients: challenges and therapeutic strategies
27. Tp53 status as guide for the management of ethmoid sinus intestinal-type adenocarcinoma
28. NR4A3 fusion molecular profile change pathological diagnosis? A case report
29. Multikinase inhibitors in thyroid cancer
30. Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor–positive salivary gland cancers
31. Temporal course and predictive factors of analgesic opioid requirement for chemoradiation-induced oral mucositis in oropharyngeal cancer
32. Major and minor salivary gland tumors
33. Multikinase inhibitors in thyroid cancer
34. Quality of life and financial toxicity after (chemo)radiation therapy in head and neck cancer: are there any sex- or gender-related differences?
35. Oral prevalence and clearance of oncogenic human papilloma virus in a rehabilitation community for substance abusers in Italy: a case of behavioral correction?
36. Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs)
37. The association of cemiplimab plus sonidegib for synchronous cutaneous squamous cell carcinoma and basal cell carcinoma of the head and neck: Two case reports.
38. Abiraterone Acetate in Patients With Castration-Resistant, Androgen Receptor–Expressing Salivary Gland Cancer: A Phase II Trial
39. Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
40. TRK-A, HER-2/neu, and KIT Expression/Activation Profiles in Salivary Gland Carcinoma
41. Managing locally advanced adenoid cystic carcinoma of the head and neck during the COVID-19 pandemic crisis: Is this the right time for particle therapy?
42. Treatment of advanced thyroid cancer with axitinib: Phase 2 study with pharmacokinetic/pharmacodynamic and quality-of-life assessments
43. Prolonged response using gefitinib followed by sirolimus for advanced cutaneous squamous cell carcinoma
44. Management of salivary gland tumors
45. Quality of Life in Patients With Hypoparathyroidism After Treatment for Thyroid Cancer
46. Tumor Biomarkers for the Prediction of Distant Metastasis in Head and Neck Squamous Cell Carcinoma
47. Lung metastasectomy in adenoid cystic carcinoma (ACC) of salivary gland
48. Biological agents in head and neck cancer
49. High-Risk Human Papillomavirus Affects Prognosis in Patients With Surgically Treated Oropharyngeal Squamous Cell Carcinoma
50. Is Restoring Platinum Sensitivity the Best Goal for Cetuximab in Recurrent/Metastatic Nasopharyngeal Cancer?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.